Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
01 2019
Historique:
received: 07 06 2018
accepted: 17 12 2018
pubmed: 25 1 2019
medline: 20 6 2019
entrez: 25 1 2019
Statut: ppublish

Résumé

Diffuse gliomas are the most common malignant brain tumours in adults and include glioblastomas and World Health Organization (WHO) grade II and grade III tumours (sometimes referred to as lower-grade gliomas). Genetic tumour profiling is used to classify disease and guide therapy

Identifiants

pubmed: 30675060
doi: 10.1038/s41586-019-0882-3
pii: 10.1038/s41586-019-0882-3
pmc: PMC6457907
mid: NIHMS1516901
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

654-658

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA092629
Pays : United States
Organisme : NINDS NIH HHS
ID : R35 NS105109
Pays : United States
Organisme : NIH HHS
ID : 1 R35 NS105109 01
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Mutat Res. 2000 May 30;450(1-2):125-38
pubmed: 10838138
Cancer Res. 2006 Apr 15;66(8):3987-91
pubmed: 16618716
Science. 2008 Sep 26;321(5897):1807-12
pubmed: 18772396
Nature. 2008 Oct 23;455(7216):1061-8
pubmed: 18772890
Brief Bioinform. 2013 Mar;14(2):178-92
pubmed: 22517427
Nature. 2012 Nov 1;491(7422):56-65
pubmed: 23128226
Nature. 2013 Aug 22;500(7463):415-21
pubmed: 23945592
Cell. 2013 Oct 10;155(2):462-77
pubmed: 24120142
Science. 2014 Jan 10;343(6167):189-193
pubmed: 24336570
Sci Transl Med. 2014 Feb 19;6(224):224ra24
pubmed: 24553385
Genome Res. 2015 Mar;25(3):316-27
pubmed: 25650244
J Mol Diagn. 2015 May;17(3):251-64
pubmed: 25801821
Nat Genet. 2015 May;47(5):458-68
pubmed: 25848751
N Engl J Med. 2015 Jun 25;372(26):2481-98
pubmed: 26061751
N Engl J Med. 2015 Jun 25;372(26):2499-508
pubmed: 26061753
Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):9704-9
pubmed: 26195750
Cancer Cell. 2015 Sep 14;28(3):318-28
pubmed: 26373279
Nat Genet. 2016 Jan;48(1):59-66
pubmed: 26618343
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
J Clin Oncol. 2016 Jul 10;34(20):2404-15
pubmed: 27161972
Nucleic Acids Res. 2016 Sep 19;44(16):e131
pubmed: 27270079
Nat Genet. 2016 Jul;48(7):768-76
pubmed: 27270107
Nat Genet. 2017 Apr;49(4):594-599
pubmed: 28263318
Acta Neuropathol Commun. 2017 Mar 7;5(1):18
pubmed: 28270234
Nat Med. 2017 Jun;23(6):703-713
pubmed: 28481359
Cancer Discov. 2017 Aug;7(8):818-831
pubmed: 28572459
J Clin Oncol. 2017 Jul 20;35(21):2439-2449
pubmed: 28640707
J Clin Oncol. 2018 Jun 1;36(16):1631-1641
pubmed: 29504847

Auteurs

Alexandra M Miller (AM)

Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Ronak H Shah (RH)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Medical Genetics and Human Genomics, Department of Pediatrics, Northwell Health, Manhasset, NY, USA.

Elena I Pentsova (EI)

Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Maryam Pourmaleki (M)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Samuel Briggs (S)

Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Natalie Distefano (N)

Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Youyun Zheng (Y)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Anna Skakodub (A)

Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Smrutiben A Mehta (SA)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Carl Campos (C)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Wan-Ying Hsieh (WY)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

S Duygu Selcuklu (SD)

Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Lilan Ling (L)

Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Fanli Meng (F)

Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Xiaohong Jing (X)

Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Aliaksandra Samoila (A)

Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Tejus A Bale (TA)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Dana W Y Tsui (DWY)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Christian Grommes (C)

Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Agnes Viale (A)

Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Mark M Souweidane (MM)

Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Department of Neurological Surgery, Weill Cornell Medical College, New York, NY, USA.

Viviane Tabar (V)

Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Cameron W Brennan (CW)

Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Anne S Reiner (AS)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Marc Rosenblum (M)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Katherine S Panageas (KS)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Lisa M DeAngelis (LM)

Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Robert J Young (RJ)

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Michael F Berger (MF)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. bergerm1@mskcc.org.
Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. bergerm1@mskcc.org.
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. bergerm1@mskcc.org.
Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA. bergerm1@mskcc.org.

Ingo K Mellinghoff (IK)

Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. mellingi@mskcc.org.
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. mellingi@mskcc.org.
Department of Pharmacology, Weill Cornell Medical College, New York, NY, USA. mellingi@mskcc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH